Skip to main content
. 2018 May 31;8:8438. doi: 10.1038/s41598-018-26860-0

Figure 2.

Figure 2

DP1 knockdown does not reduce E2F1 activation of the ARF promoter or binding of deregulated E2F1. (A) Reporter analysis of CDC6 and ARF promoters by ectopic expression of E2F1 in WI-38 cells expressing DP1-shRNA. *P < 0.05. (B) Gel mobility shift assays with extracts from WI-38 cells ectopically expressing E2F1 and DP1-shRNA. Probes were a DHFR promoter fragment containing typical E2F sites (left panel) and EREA (right panel). Competitors were an adenovirus E2 enhancer fragment containing typical E2F sites (E2 wt) and its mutant (E2 mt). Ad-shCon and Ad-shDP1-2 data were on the same gels with the same exposure (Supplementary Fig. S7). (C) ChIP analysis of E2F target promoters in WI-38 cells ectopically expressing E2F1 and DP1-shRNA. Full-length gels are presented in Supplementary Fig. S8.